Fredericus Colen
Director/Board Member at ONWARD MEDICAL N.V.
Net worth: 356 081 $ as of 2024-04-29
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Grégoire Courtine | M | 49 |
Onward Medical SA
Onward Medical SA BiotechnologyHealth Technology ONWARD Inc develops medical devices. It also provides stimulation system to rehabilitate individuals with spinal cord injury. The company was founded by Jocelyn Bloch, Sjaak Deckers, Grégoire Courtine, and Vincent Delattre in December 2014 and is headquartered in Lausanne, Switzerland. | 10 years |
Vincent Delattre | M | - |
Onward Medical SA
Onward Medical SA BiotechnologyHealth Technology ONWARD Inc develops medical devices. It also provides stimulation system to rehabilitate individuals with spinal cord injury. The company was founded by Jocelyn Bloch, Sjaak Deckers, Grégoire Courtine, and Vincent Delattre in December 2014 and is headquartered in Lausanne, Switzerland. | 10 years |
Matthew Liotta | M | 45 | 3 years | |
Ian Curtis | M | 56 |
Onward Medical SA
Onward Medical SA BiotechnologyHealth Technology ONWARD Inc develops medical devices. It also provides stimulation system to rehabilitate individuals with spinal cord injury. The company was founded by Jocelyn Bloch, Sjaak Deckers, Grégoire Courtine, and Vincent Delattre in December 2014 and is headquartered in Lausanne, Switzerland. | 5 years |
Jonathan Monson | M | 50 | 16 years | |
Jan Öhrström | M | 67 |
Onward Medical SA
Onward Medical SA BiotechnologyHealth Technology ONWARD Inc develops medical devices. It also provides stimulation system to rehabilitate individuals with spinal cord injury. The company was founded by Jocelyn Bloch, Sjaak Deckers, Grégoire Courtine, and Vincent Delattre in December 2014 and is headquartered in Lausanne, Switzerland. | 8 years |
David Marver | M | - |
Onward Medical SA
Onward Medical SA BiotechnologyHealth Technology ONWARD Inc develops medical devices. It also provides stimulation system to rehabilitate individuals with spinal cord injury. The company was founded by Jocelyn Bloch, Sjaak Deckers, Grégoire Courtine, and Vincent Delattre in December 2014 and is headquartered in Lausanne, Switzerland. | 4 years |
Nicholas Cooper | M | 38 | 3 years | |
Vance Brown | M | 54 | 23 years | |
Keith Rabin | M | 52 | - | |
Andy Dolan | M | - |
Onward Medical SA
Onward Medical SA BiotechnologyHealth Technology ONWARD Inc develops medical devices. It also provides stimulation system to rehabilitate individuals with spinal cord injury. The company was founded by Jocelyn Bloch, Sjaak Deckers, Grégoire Courtine, and Vincent Delattre in December 2014 and is headquartered in Lausanne, Switzerland. | 3 years |
Vivian Riefberg | F | 63 | 2 years | |
Martijn Cox | M | - |
Xeltis AG
Xeltis AG Medical SpecialtiesHealth Technology Xeltis AG develops medical devices to transform standards of care in heart valve replacement and vascular surgery. It develops fully bio absorbable synthetic heart valves and vascular grafts intended to enable for the first time the spontaneous growth of natural, healthy valves and vessels. Its medical device platform comprises bioabsorbable heart valves and blood vessels, designed to enable Endogenous Tissue Restoration (ETR), the natural restoration of the complex body part they replace upon implantation. The company was founded by Martijn Cox, Laurent Grandidier and Simon P. Hoerstrup in 2006 and is headquartered in Zurich, Switzerland. | 18 years |
Barry McBride | M | - |
Mölnlycke Health Care AB
Mölnlycke Health Care AB Medical SpecialtiesHealth Technology Mölnlycke Health Care AB manufactures surgical and wound care products. It offers custom procedure trays, examination gloves, dental products, staff clothing, surgical drapes and absorbent dressings. The firm's brands include BARRIER, Biogel, HiBi and ProcedurePak, Mepilex, Mepitel, Mepore, Mefix, Tubifast, Tubigrip and Xelma. The company was founded by Gustaf Ferdinand Hennig in 1849 and is headquartered in Goteborg, Sweden. | 10 years |
George Fazio | M | 64 |
Xeltis AG
Xeltis AG Medical SpecialtiesHealth Technology Xeltis AG develops medical devices to transform standards of care in heart valve replacement and vascular surgery. It develops fully bio absorbable synthetic heart valves and vascular grafts intended to enable for the first time the spontaneous growth of natural, healthy valves and vessels. Its medical device platform comprises bioabsorbable heart valves and blood vessels, designed to enable Endogenous Tissue Restoration (ETR), the natural restoration of the complex body part they replace upon implantation. The company was founded by Martijn Cox, Laurent Grandidier and Simon P. Hoerstrup in 2006 and is headquartered in Zurich, Switzerland. | 4 years |
Roel Bulthuis | M | - |
Onward Medical SA
Onward Medical SA BiotechnologyHealth Technology ONWARD Inc develops medical devices. It also provides stimulation system to rehabilitate individuals with spinal cord injury. The company was founded by Jocelyn Bloch, Sjaak Deckers, Grégoire Courtine, and Vincent Delattre in December 2014 and is headquartered in Lausanne, Switzerland. | - |
John Sununu | M | 59 | 15 years | |
John Paul de Koning | M | 55 |
Onward Medical SA
Onward Medical SA BiotechnologyHealth Technology ONWARD Inc develops medical devices. It also provides stimulation system to rehabilitate individuals with spinal cord injury. The company was founded by Jocelyn Bloch, Sjaak Deckers, Grégoire Courtine, and Vincent Delattre in December 2014 and is headquartered in Lausanne, Switzerland. | 8 years |
Brenda Becker | F | 64 | 17 years | |
Regina Hodits | M | 53 |
Onward Medical SA
Onward Medical SA BiotechnologyHealth Technology ONWARD Inc develops medical devices. It also provides stimulation system to rehabilitate individuals with spinal cord injury. The company was founded by Jocelyn Bloch, Sjaak Deckers, Grégoire Courtine, and Vincent Delattre in December 2014 and is headquartered in Lausanne, Switzerland. | 8 years |
Michael Nichols | M | 53 | 3 years | |
John Sorenson | M | 56 | 22 years | |
Mark Heinen | M | 54 | 1 years | |
Matthew Hua | M | - |
Xeltis AG
Xeltis AG Medical SpecialtiesHealth Technology Xeltis AG develops medical devices to transform standards of care in heart valve replacement and vascular surgery. It develops fully bio absorbable synthetic heart valves and vascular grafts intended to enable for the first time the spontaneous growth of natural, healthy valves and vessels. Its medical device platform comprises bioabsorbable heart valves and blood vessels, designed to enable Endogenous Tissue Restoration (ETR), the natural restoration of the complex body part they replace upon implantation. The company was founded by Martijn Cox, Laurent Grandidier and Simon P. Hoerstrup in 2006 and is headquartered in Zurich, Switzerland. | 12 years |
Sarah Gallagher | F | - | 3 years | |
Lisa Becker | F | - | 3 years | |
Colin Morrison | M | - | 22 years | |
Kristina Dziekan | F | - | 2 years | |
Charlie Attlan | M | - | 14 years | |
Erika Ross | M | - | 1 years | |
John Murphy | M | 57 | 4 years | |
Oleg Svanidze | M | - |
Xeltis AG
Xeltis AG Medical SpecialtiesHealth Technology Xeltis AG develops medical devices to transform standards of care in heart valve replacement and vascular surgery. It develops fully bio absorbable synthetic heart valves and vascular grafts intended to enable for the first time the spontaneous growth of natural, healthy valves and vessels. Its medical device platform comprises bioabsorbable heart valves and blood vessels, designed to enable Endogenous Tissue Restoration (ETR), the natural restoration of the complex body part they replace upon implantation. The company was founded by Martijn Cox, Laurent Grandidier and Simon P. Hoerstrup in 2006 and is headquartered in Zurich, Switzerland. | - |
Milad Girgis | M | - | 20 years | |
Mark Bickel | M | - | 17 years | |
Norman J. Radow | M | - | 5 years | |
Khaled Bahi | M | - | 1 years | |
Patrick van Beneden | M | 62 |
Onward Medical SA
Onward Medical SA BiotechnologyHealth Technology ONWARD Inc develops medical devices. It also provides stimulation system to rehabilitate individuals with spinal cord injury. The company was founded by Jocelyn Bloch, Sjaak Deckers, Grégoire Courtine, and Vincent Delattre in December 2014 and is headquartered in Lausanne, Switzerland. | - |
Vanessa Malier | F | 51 |
Xeltis AG
Xeltis AG Medical SpecialtiesHealth Technology Xeltis AG develops medical devices to transform standards of care in heart valve replacement and vascular surgery. It develops fully bio absorbable synthetic heart valves and vascular grafts intended to enable for the first time the spontaneous growth of natural, healthy valves and vessels. Its medical device platform comprises bioabsorbable heart valves and blood vessels, designed to enable Endogenous Tissue Restoration (ETR), the natural restoration of the complex body part they replace upon implantation. The company was founded by Martijn Cox, Laurent Grandidier and Simon P. Hoerstrup in 2006 and is headquartered in Zurich, Switzerland. | - |
Kenneth Stein | M | - | 15 years | |
Steven Drucker | M | 53 | - | |
Eliane Schutte | F | - |
Xeltis AG
Xeltis AG Medical SpecialtiesHealth Technology Xeltis AG develops medical devices to transform standards of care in heart valve replacement and vascular surgery. It develops fully bio absorbable synthetic heart valves and vascular grafts intended to enable for the first time the spontaneous growth of natural, healthy valves and vessels. Its medical device platform comprises bioabsorbable heart valves and blood vessels, designed to enable Endogenous Tissue Restoration (ETR), the natural restoration of the complex body part they replace upon implantation. The company was founded by Martijn Cox, Laurent Grandidier and Simon P. Hoerstrup in 2006 and is headquartered in Zurich, Switzerland. | 6 years |
Clemens A. van Blitterswijk | M | 67 |
Xeltis AG
Xeltis AG Medical SpecialtiesHealth Technology Xeltis AG develops medical devices to transform standards of care in heart valve replacement and vascular surgery. It develops fully bio absorbable synthetic heart valves and vascular grafts intended to enable for the first time the spontaneous growth of natural, healthy valves and vessels. Its medical device platform comprises bioabsorbable heart valves and blood vessels, designed to enable Endogenous Tissue Restoration (ETR), the natural restoration of the complex body part they replace upon implantation. The company was founded by Martijn Cox, Laurent Grandidier and Simon P. Hoerstrup in 2006 and is headquartered in Zurich, Switzerland. | - |
Diego Braguglia | M | 58 |
Xeltis AG
Xeltis AG Medical SpecialtiesHealth Technology Xeltis AG develops medical devices to transform standards of care in heart valve replacement and vascular surgery. It develops fully bio absorbable synthetic heart valves and vascular grafts intended to enable for the first time the spontaneous growth of natural, healthy valves and vessels. Its medical device platform comprises bioabsorbable heart valves and blood vessels, designed to enable Endogenous Tissue Restoration (ETR), the natural restoration of the complex body part they replace upon implantation. The company was founded by Martijn Cox, Laurent Grandidier and Simon P. Hoerstrup in 2006 and is headquartered in Zurich, Switzerland. | 9 years |
Christian C. Wenger | M | 60 |
Xeltis AG
Xeltis AG Medical SpecialtiesHealth Technology Xeltis AG develops medical devices to transform standards of care in heart valve replacement and vascular surgery. It develops fully bio absorbable synthetic heart valves and vascular grafts intended to enable for the first time the spontaneous growth of natural, healthy valves and vessels. Its medical device platform comprises bioabsorbable heart valves and blood vessels, designed to enable Endogenous Tissue Restoration (ETR), the natural restoration of the complex body part they replace upon implantation. The company was founded by Martijn Cox, Laurent Grandidier and Simon P. Hoerstrup in 2006 and is headquartered in Zurich, Switzerland. | 10 years |
Wendy Carruthers | F | 55 | 20 years | |
Sarah Moore | F | - | 1 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Timothy A. Pratt | M | 74 | 9 years | |
James Tobin | M | 79 | 10 years | |
Jeffrey Capello | M | 69 | 5 years | |
John Raymond Elliott | M | 74 | 3 years | |
Helen Ljungdahl Round | F | 60 | 1 years | |
Michael V. Chobotov | M | 63 | 4 years | |
Richard Michael Twomey | M | 60 |
Mölnlycke Health Care AB
Mölnlycke Health Care AB Medical SpecialtiesHealth Technology Mölnlycke Health Care AB manufactures surgical and wound care products. It offers custom procedure trays, examination gloves, dental products, staff clothing, surgical drapes and absorbent dressings. The firm's brands include BARRIER, Biogel, HiBi and ProcedurePak, Mepilex, Mepitel, Mepore, Mefix, Tubifast, Tubigrip and Xelma. The company was founded by Gustaf Ferdinand Hennig in 1849 and is headquartered in Goteborg, Sweden. | 6 years |
Sam Leno | M | 78 | 4 years | |
Michael Berman | M | 66 |
BeneChill, Inc.
BeneChill, Inc. Medical SpecialtiesHealth Technology BeneChill, Inc. develops non-invasive cooling technology for cerebral ischemia treatment. The company was founded by Michael L. Berman and Denise Barbut in 2004 is headquartered in San Diego, CA. | 12 years |
Jason Papastavrou | M | 61 |
BeneChill, Inc.
BeneChill, Inc. Medical SpecialtiesHealth Technology BeneChill, Inc. develops non-invasive cooling technology for cerebral ischemia treatment. The company was founded by Michael L. Berman and Denise Barbut in 2004 is headquartered in San Diego, CA. | - |
Kristen Ambrose | F | 47 | 18 years | |
David Milne | M | 61 | 6 years | |
Maulik Nanavaty | M | 62 | - | |
Pierre Roger Michel Guyot | M | 60 |
Mölnlycke Health Care AB
Mölnlycke Health Care AB Medical SpecialtiesHealth Technology Mölnlycke Health Care AB manufactures surgical and wound care products. It offers custom procedure trays, examination gloves, dental products, staff clothing, surgical drapes and absorbent dressings. The firm's brands include BARRIER, Biogel, HiBi and ProcedurePak, Mepilex, Mepitel, Mepore, Mefix, Tubifast, Tubigrip and Xelma. The company was founded by Gustaf Ferdinand Hennig in 1849 and is headquartered in Goteborg, Sweden. | 7 years |
William Walter O'Neill | M | 73 | 11 years | |
Milton Morris | M | 54 | 11 years | |
Katharine T. Bartlett | F | 77 | - | |
Vicki Bebeau | F | 74 | 9 years | |
Bruce L. Byrnes | M | 75 | 6 years | |
Nelda Connors | F | 58 | 15 years | |
Lawrence C. Best | M | 75 | 15 years | |
Mary E. Russell | M | 68 | 6 years | |
Geoffrey Rose | M | 50 | 8 years | |
Arthur Rosenthal | M | 77 | 11 years | |
John Onuscheck | M | 57 | - | |
Scott William Kraus | M | 54 | - | |
Keith Dawkins | M | 73 | 9 years | |
Stefan Ulf Fristedt | M | 58 |
Mölnlycke Health Care AB
Mölnlycke Health Care AB Medical SpecialtiesHealth Technology Mölnlycke Health Care AB manufactures surgical and wound care products. It offers custom procedure trays, examination gloves, dental products, staff clothing, surgical drapes and absorbent dressings. The firm's brands include BARRIER, Biogel, HiBi and ProcedurePak, Mepilex, Mepitel, Mepore, Mefix, Tubifast, Tubigrip and Xelma. The company was founded by Gustaf Ferdinand Hennig in 1849 and is headquartered in Goteborg, Sweden. | - |
Ernest Mario | M | 85 | 15 years | |
Jane Hsaio | M | 77 | 11 years | |
Paul W. Sandman | M | 76 | 15 years | |
Uwe E. Reinhardt | M | 87 | 13 years | |
Kevin C. Smith | M | 63 | 11 years | |
Lorenzo Chiozzia | M | - | - | |
Kathy Horton | F | - | 7 years | |
James R. Chiapetta | M | - | - | |
Jay Millerhagen | M | - | 18 years | |
Xavier K. Bertrand | M | 52 | 9 years | |
Warren B. Rudman | M | 94 | 11 years | |
Maria Palasis | M | 59 | 13 years | |
René Spaargaren | M | - | 7 years | |
Rob A. Abrams | M | - | - | |
Frederick Hrkac | M | 58 | 2 years | |
Jacques Gutedel | M | - | - | |
Jeffrey Jones | M | 68 | 5 years | |
Amr Salahieh | M | - | 4 years | |
David R. Kressler | M | - | 14 years | |
David Toohey | M | 67 | 6 years | |
Michael J. Ryan | M | 45 | - | |
Paul LaViolette | M | 66 | 14 years | |
Robert Bernard Hargadon | M | 67 | 8 years | |
Henry C. Tung | M | 65 | 5 years | |
Henry Kay | M | 79 | 10 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 57 | 57.58% |
Switzerland | 19 | 19.19% |
Netherlands | 15 | 15.15% |
Canada | 6 | 6.06% |
Sweden | 5 | 5.05% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Fredericus Colen
- Personal Network